Lanean...
Treatment of Isoniazid-Resistant Pulmonary Tuberculosis
Tuberculosis (TB) remains a threat to public health and is the leading cause of death globally. Isoniazid (INH) is an important first-line agent for the treatment of TB considering its early bactericidal activity. Resistance to INH is now the most common type of resistance. Resistance to INH reduces...
Gorde:
| Egile Nagusiak: | , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
The Korean Academy of Tuberculosis and Respiratory Diseases
2020-01-01
|
| Saila: | Tuberculosis and Respiratory Diseases |
| Gaiak: | |
| Sarrera elektronikoa: | https://e-trd.org/search.php?where=aview&id=10.4046/trd.2019.0065&code=0003TRD&vmode=FULL |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|